Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.710
-0.210 (-4.27%)
Dec 5, 2025, 4:00 PM EST - Market closed
Recursion Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,455 | 2,666 | 2,136 | 1,461 | 2,895 | - | |
| Market Cap Growth | 36.51% | 24.83% | 46.15% | -49.52% | - | - | |
| Enterprise Value | 1,878 | 2,329 | 1,800 | 1,059 | 2,317 | - | |
| Last Close Price | 4.71 | 6.76 | 9.86 | 7.71 | 17.13 | - | |
| PS Ratio | 43.24 | 45.32 | 47.92 | 36.68 | 284.42 | - | |
| PB Ratio | 2.21 | 2.58 | 4.61 | 3.01 | 5.33 | - | |
| P/TBV Ratio | 4.36 | 4.85 | 5.70 | 3.02 | 5.35 | - | |
| EV/Sales Ratio | 42.98 | 39.59 | 40.38 | 26.58 | 227.62 | - | |
| Debt / Equity Ratio | 0.08 | 0.11 | 0.11 | 0.11 | 0.00 | 0.05 | |
| Asset Turnover | 0.04 | 0.06 | 0.07 | 0.06 | 0.02 | 0.02 | |
| Quick Ratio | 4.39 | 3.43 | 4.24 | 5.51 | 11.27 | 11.36 | |
| Current Ratio | 4.60 | 3.81 | 4.70 | 5.68 | 11.46 | 11.54 | |
| Return on Equity (ROE) | -91.06% | -61.90% | -69.12% | -46.56% | -47.51% | -54.57% | |
| Return on Assets (ROA) | -42.20% | -28.48% | -32.29% | -23.42% | -25.14% | -26.44% | |
| Return on Capital (ROIC) | -51.43% | -36.13% | -41.64% | -28.43% | -28.62% | -30.76% | |
| Return on Capital Employed (ROCE) | -57.70% | -38.00% | -62.50% | -40.90% | -32.40% | -30.70% | |
| Earnings Yield | -29.14% | -17.39% | -15.36% | -16.39% | -6.44% | - | |
| FCF Yield | -18.23% | -13.98% | -14.03% | -8.25% | -6.85% | - | |
| Buyback Yield / Dilution | -63.30% | -31.92% | -18.41% | -40.04% | -475.48% | -0.98% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.